No Influence of Dabigatran Anticoagulation on Hemorrhagic Transformation in an Experimental Model of Ischemic Stroke

BACKGROUND: Dabigatran etexilate (DE) is a new oral direct thrombin inhibitor. Clinical trials point towards a favourable risk-to-benefit profile of DE compared to warfarin. In this study, we evaluated whether hemorrhagic transformation (HT) occurs after experimental stroke under DE treatment as we...

Descripción completa

Detalles Bibliográficos
Autores principales: Bohmann, Ferdinand, Mirceska, Ana, Pfeilschifter, Josef, Lindhoff-Last, Edelgard, Steinmetz, Helmuth, Foerch, Christian, Pfeilschifter, Waltraud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3404053/
https://www.ncbi.nlm.nih.gov/pubmed/22911709
http://dx.doi.org/10.1371/journal.pone.0040804

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3404053/
https://www.ncbi.nlm.nih.gov/pubmed/22911709
http://dx.doi.org/10.1371/journal.pone.0040804

Ejemplares similares